A middle-aged ASA II patient with obstructive sleep apnoea and a BMI of 35 kg.m 22 required a total thyroidectomy. The patient had limited cervical spine mobility, tracheal deviation and it was noted that a surgical airway would be difficult. A spontaneously breathing general anaesthetic was performed using propofol and remifentanil. Direct laryngoscopy showed a grade 3 view and during repositioning complete airway obstruction followed with inability to mask ventilate despite six-handed ventilation. Several unsuccessful attempts at needle cricothyroidotomy, both fine and large bore, were made and the airway was finally secured after a difficult tracheostomy. The patient spent 20 minutes with oxygen saturations of less than 50% and received elective ventilation to manage cerebral hypoxia. A full recovery was reported.
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NAP4-Major Complications of Airway Management in the UK. 1 Serious morbidity and mortality related to airway management remains a major issue in anaesthesia in the UK. The fourth national audit project (NAP4) of the Royal College of Anaesthetists recently highlighted the underuse of awake fibreoptic intubation (AFOI) in the management of difficult airways, and also identified a number of factors leading to its failure, such as inappropriate sedation, inability to view landmarks, and tracheal tube (TT) impingement during railroading. 1 The lack of experience and familiarity with AFOI are likely to contribute significantly to this lack of use. It is vital to consider awake intubation for difficult airway management, and the equipment and expertise should be available when required. Awake intubation may be indicated when there is known or suspected difficulty with mask ventilation or tracheal intubation (Table 1) . In cases of isolated difficult direct laryngoscopy, where mask ventilation is possible, asleep techniques may be more appropriate. Under these circumstances, video laryngoscopy is gaining popularity as part of the anaesthetists' repertoire in management of the difficult airway. Absolute contraindications to awake intubation are limited to patient refusal, despite adequate counselling regarding risks and benefits, and non-compliance. Relative contraindications include operator inexperience, local anaesthetic allergy, and airway bleeding. Some debate exists as to the safety of AFOI in the patient at risk of aspiration, but numerous reports of its success exist. AFOI in patients with upper airway tumours, in particular those presenting with stridor, remains controversial because of the potential for complete airway obstruction, but is successfully used by experts in selected cases. Decision-making in these circumstances can be aided by preoperative nasendoscopy and radiological investigations. The AFOI is often the first technique that comes to mind when awake intubation is considered, but numerous alternatives exist. These include conventional direct laryngoscopy, blind nasal intubation, the intubating laryngeal mask, tracheostomy, and more recently video laryngoscopy. Awake tracheostomy is of particular benefit in those whom AFOI may precipitate total airway obstruction.
Awake video laryngoscopy
Video laryngoscopy is becoming established as a very useful technique in the management of difficult direct laryngoscopy. Since its introduction, it has been increasingly used to facilitate awake intubation. It has been proposed that because of similarities to conventional laryngoscopy, and more familiar psychomotor skills, that awake video laryngoscopy may in fact be easier, faster, and safer to perform than AFOI in the patient with an anticipated difficult airway, although evidence to support this is lacking. A recent randomized controlled trial demonstrated no difference in time to tracheal intubation in patients with anticipated difficult airways. 2 Owing to circumstances where awake video laryngoscopy will not be possible, such as extremely limited mouth opening, the authors would argue that AFOI supersedes awake video laryngoscopy as the technique of choice for difficult direct laryngoscopy. Issues regarding lack of familiarity
Key points
Awake intubation is underused in the UK.
All forms of tracheal intubation, including tracheostomy, can be performed under local anaesthesia.
Sedation may enhance the acceptability of awake intubation in some patients, but may also lead to airway obstruction and therefore requires careful administration and monitoring.
Increased use of awake intubation requires improvements in training.
Awake video laryngoscopy is emerging as a useful alternative to awake fibreoptic intubation.
and appropriate psychomotor skills should be addressed through improved training, rather than searching for alternative techniques. For these reasons, the remainder of this review will concentrate on AFOI.
Awake fibreoptic intubation
Fibreoptic intubation was first performed by Dr Peter Murphy in 1967 using a surgical choledochoscope. The potential applications for airway management were soon realized and reports of AFOI appeared over the next few years. This review will guide the reader through options for airway preparation and sedation, and describe techniques for performing and teaching AFOI.
Airway preparation

Anti-sialogogues
Glycopyrrolate 4 mg kg 21 given i.m. an hour before intubation dries mucus membranes which both increases the efficacy of topical anaesthesia, and improves intubating conditions by decreasing secretions. Alternatively, i.v. glycopyrrolate may be injected in the anaesthetic room, although unwanted side-effects such as tachycardia may be more problematic. Other options include atropine and hyoscine. The tachycardia associated with antimuscarinics can sometimes make awake intubation more difficult as a result of increased patient anxiety secondary to tachycardia.
Local anaesthetics
Lidocaine is the most widely used agent for topical airway anaesthesia. It is available in a variety of concentrations, and in combination with vasoconstrictors such as epinephrine and phenylephrine. The maximum described dose for topical administration 3 is 9 mg kg 21 although with proficient fibreoptic scope skills, doses this high should not be necessary. High doses of local anaesthetics should be used with caution, particularly in patients with liver disease. Cocaine has the benefit of intrinsic vasoconstrictor activity, but concerns regarding its toxicity have resulted in a decline in its use. Local anaesthetics can be nebulized, administered by a 'spray-asyou-go' technique using a variety of administration devices, or via a number of 'airway blocks' which have been covered previously in this journal. 4 Cricothyroid puncture and transtracheal local anaesthetic injection can provide excellent airway anaesthesia. In addition, if performed with a suitable cannula, it can used for rescue oxygenation, and provide a conduit for passage of a guidewire facilitating Seldinger tracheostomy in cases of failed fibreoptic intubation or airway obstruction.
Sedation
Although awake intubation can be achieved using local anaesthesia alone, sedation is often required to enable improved patient tolerance. Drugs commonly used for sedation during awake intubation tend to be either primarily anxiolytic or analgesic, although some newer agents demonstrate both properties. The safety of awake intubation relies on the maintenance of spontaneous breathing, and the ability to stop and perform a different technique, such as awake tracheostomy, if intubation is unsuccessful. Oversedation can cause airway obstruction, respiratory depression, or apnoea, resulting in significant morbidity or mortality as highlighted by NAP4. It therefore seems a logical recommendation that a second anaesthetist, or 'sedationist' be responsible for administering and monitoring the effects of sedation. A number of drugs and regimens are available for sedation during awake intubation, and as yet there is a lack of well-designed randomized controlled trials comparing these regimes. As a result of the relatively small number of patients in whom AFOI is undertaken, these data are likely to be hard to come by, and debate regarding optimal sedation technique is likely to continue.
Midazolam
Midazolam is a benzodiazepine that can be injected in boluses of 0.5-1 mg, usually not exceeding 0.05 mg kg
21
. Because of its lack of analgesic properties, it is commonly used in conjunction with fentanyl boluses up to 1.5 mg kg 21 . The main benefits of this technique are its simplicity and widespread experience of its use. The added advantage of amnesia may improve patient experience and result in improved compliance with any future awake intubations, although there is no evidence to support this. Bolus injection can result in oversedation, and so it should be remembered that its effects can be antagonized with flumazenil.
Remifentanil
Remifentanil is now very widely used during AFOI. It is a potent m-opioid receptor agonist, with the advantage over other opioids of a very rapid offset of action. This is due to hydrolysis by non-specific plasma and tissue esterases, independent of renal and hepatic function. It has excellent anti-tussive and analgesic properties, and has been used as a sole agent for AFOI, even without airway topicalization. It is commonly used in conjunction with other agents, such as midazolam, or more recently propofol, in order to reduce the high incidence of recall. Interestingly, however, patients who do have recall when remifentanil is used do not describe the experience as unpleasant. Remifentanil has numerous side-effects that are potentially problematic during AFOI. These include bradycardia, hypotension, apnoea, hypoxia, and chest wall rigidity, and it is the use of remifentanil that has drawn our attention to the need for a second anaesthetist to provide sedation and monitor the patient. 1 Many advocates of its use advise against using it in combination with other sedatives, in order to minimize these side-effects. Injection using a target-controlled infusion (TCI) has been shown to reduce the incidence of complications, and provides better intubating conditions. On published evidence, when used in combination with midazolam or propofol, an effect-site concentration of 3 -5 ng ml 21 is said to be appropriate. 5 The authors' own experiences suggest that effect-site concentrations of 1-2 ng ml 21 are perfectly adequate.
Propofol
Propofol is a highly lipid-soluble alkylphenol derivative that can be injected in boluses, as a simple infusion, or as a TCI. The vast majority of studies looking at its use for sedation during awake intubation have been with TCI. Achieving the correct balance between undersedation and oversedation can be extremely challenging when using propofol as a sole sedative agent, with effect-site concentrations of .3 mg ml 21 seemingly associated with increased likelihood of oversedation. Concomitant administration of opioids or benzodiazepines can improve efficacy. Current evidence would suggest that propofol is best used as TCI with effect-site concentrations up to 1 mg ml 21 , in conjunction with remifentanil. 5 
Dexmedetomidine
Dexmedetomidine is an imidazole compound that has specific a-2 adrenoceptor agonist activity. It is gaining popularity as a sedative agent for AFOI because of a number of favourable properties. In addition to sedation, it also provides anterograde amnesia, anxiolysis, and analgesia. Importantly, it also has minimal effects on respiration. It is injected as a bolus of 0.7-1 mg kg 21 over 10-20 min followed by an infusion of 0.3-0.7 mg kg 21 h 21 . Despite these numerous desirable characteristics, there is currently a lack of well-designed randomized controlled trials demonstrating any clear benefit over other agents. 5 
Oxygen
Because of the circumstances under which awake intubation is usually performed, administration of supplemental oxygen is invariably appropriate. This can be via nasal cannulae for oral intubation, or an upside-down face mask placed over the mouth for nasal intubation. It provides a safety barrier for the rare circumstances where awake intubation precipitates complete airway obstruction.
Acupuncture and acupressure
The use of acupuncture and acupressure for suppression of the gag reflex is well documented in dental and orthodontic literature, but is yet to be described in relation to awake intubation. Acupuncture points PC 6 and CV 24 ( Fig. 1 ) have both been shown to reduce severity of gagging in patients undergoing dental procedures. 6 Although no evidence exists to support the use of acupuncture or acupressure for awake intubation, it may be an interesting area for future study, particularly in patients with a problematic gag reflex, or local anaesthetic sensitivity.
Technique
The senior author's technique for AFOI is summarized below. It has been carefully modified through years of practice, and has been successful in several hundreds of patients.
In the presence of two experienced anaesthetists, the patient is sat in the semirecumbent position, monitoring attached as per Association of Anaesthetists of Great Britain and Ireland (AAGBI) recommendations, and i.v. access obtained. The scope is preloaded with a size 6.0 cuffed, reinforced TT, and an epidural catheter threaded down the suction port. Operator, patient, and screen are aligned for optimal comfort. Airway anaesthesia and sedation are achieved as summarized in Table 2 . Intubation is then performed and TT position is checked by visualization of the carina through the TT and capnography. Anaesthesia is then induced using sevoflurane, the cuff inflated, and, if necessary, a neuromuscular blocking agent injected. TT position is then further confirmed by auscultation.
Training
Perhaps the most vital aspect of increasing the use of AFOI is improved training. The authors would advocate a stepwise approach to learning the skill of AFOI (Fig. 2) . Manikins and simulators have revolutionized anaesthetic training over recent years and their importance cannot be underestimated. They provide a safe, validated introduction to the use of fibreoptic scopes, and as little as 2-4 h of specialized manikin training has been shown to provide adequate scope skills to enable tracheal intubation in patients. 7 Proceeding from manikin training to asleep fibreoptic intubations allows operators to gain an appreciation of the differences between manikins and patients, without the anxiety of intubating awake patients. It is also a vital skill in the management of the unexpected difficult intubation. From this stage, we would advocate progression to AFOI with predicted normal anatomy, and then to increasingly abnormal airway anatomy. Competence should be demonstrated at each stage before progression to the next. A didactic teaching method of fibreoptic intubation on manikins has recently been evaluated by the senior author combining audiovisual analysis and feedback, with software that enables quantitative assessment. This method improved fibreoptic intubation performance, over and above the individual's preferred technique, and novices were very quickly able to improve timing of scope insertion from the nose or mouth to carina (Table 3) .
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None declared. Stand face to face whether asleep or awake (context-specific training) Left hand holds scope with lever between eyebrows of the patient, putting epiglottis at the top of the screen (where you are used to seeing it) Right hand guides scope and inserts TT Keep scope straight (very important) Awake patient or good jaw thrust from assistant to create airspace For oral approach, measure distance from angle of mouth to tragus, pass the scope through the mouth in one movement, keeping in the midline and avoiding contact with the tongue and you should land on the glottis For nasal approach, look at both nostrils and choose largest (practice nasendoscopy whenever possible) Always adjust the scope to keep the glottis, in the centre of the screen-think of it as moving the trachea over the scope, not the other way round After passing the scope into the trachea, keep it above the carina and gently pass the TT using a screwing action
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